Rodriguez Del Rio, PabloCaimmi, DavideRico, PilarVidal, CarmenCarmen, MorenoPintoiu, Ileana MBeitia Mazuecos, Jose MGonzalez de Olano, DavidCuesta Alvaro, PedroDemoly, PascalCalderon, Moises A2023-05-032023-05-032021-11-04Rodriguez Del Rio P, Caimmi D, Rico P, Vidal C, Carmen M, Pintoiu IM, et al. Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain. Clin Exp Allergy. 2022 Jan;52(1):167-170http://hdl.handle.net/10668/19923The COVID-19 pandemic represents a global health crisis and a challenge at all societal, economic and health levels. With the first cases having been reported in most of the European countries in January 2020,1 it was not until March that the pandemic hit the territory and lead to an unprecedent hard lock-down in most countries.enAnti-allergic agentsCOVID-19Desensitization, immunologicFranceHumansHypersensitivityPractice patterns, physicians'QuarantineSARS-CoV-2Spainresearch article34747540open accessCuarentenaEspañaHipersensibilidadPautas de la práctica en medicina10.1111/cea.140431365-2222PMC8653094https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653094https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653094/pdf